Viral modulation of NK cell immunity (original) (raw)

• Lanier, L. L. NK cell receptors. Annu. Rev. Immunol. 16, 359–393 (1998).
  Article CAS PubMed Google Scholar
• Lanier, L. L. NK cell recognition. Annu. Rev. Immunol. 23, 2005 (in the press).
• Vilches, C. & Parham, P. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu. Rev. Immunol. 20, 217–251 (2002).
  Article CAS PubMed Google Scholar
• Anderson, S. K., Ortaldo, J. R. & McVicar, D. W. The ever-expanding Ly49 gene family: repertoire and signaling. Immunol. Rev. 181, 79–89 (2001).
  Article CAS PubMed Google Scholar
• Braud, V. M. & McMichael, A. J. Regulation of NK cell functions through interaction of the CD94/NKG2 receptors with the nonclassical class I molecule HLA-E. Curr. Top. Microbiol. Immunol. 244, 85–95 (1999).
  CAS PubMed Google Scholar
• Ljunggren, H. -G. & Karre, K. Host resistance directed selectively against H-2-deficient lymphoma variants: analysis of the mechanism. J. Exp. Med. 162, 1745–1759 (1985).
  Article CAS PubMed Google Scholar
• Lanier, L. L. On guard — activating NK cell receptors. Nature Immunol. 2, 23–27 (2001).
  Article CAS Google Scholar
• Krug, A. et al. Herpes simplex virus type 1 activates murine natural interferon-producing cells through Toll-like receptor 9. Blood 103, 1433–1437 (2004).
  Article CAS PubMed Google Scholar
• Krug, A. et al. TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity 21, 107–119 (2004). References 8 and 9 show that Toll-like receptors initiate interferon secretion in response to viral infection, which in turn stimulates an NK cell response.
  Article CAS PubMed Google Scholar
• Tay, C. H. & Welsh, R. M. Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells. J. Virol. 71, 267–275 (1997).
  CAS PubMed PubMed Central Google Scholar
• Lee, R. K., Spielman, J., Zhao, D. Y., Olsen, K. J. & Podack, E. R. Perforin, Fas ligand, and tumor necrosis factor are the major cytotoxic molecules used by lymphokine-activated killer cells. J. Immunol. 157, 1919–1925 (1996).
  CAS PubMed Google Scholar
• Sutton, V. R. et al. Initiation of apoptosis by granzyme B requires direct cleavage of Bid, but not direct granzyme B-mediated caspase activation. J. Exp. Med. 192, 1403–1414 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Pinkoski, M. J. et al. Granzyme B-mediated apoptosis proceeds predominantly through a Bcl-2-inhibitable mitochondrial pathway. J. Biol. Chem. 276, 12060–12067 (2001).
  Article CAS PubMed Google Scholar
• Reddehase, M. J. Antigens and immunoevasins: opponents in cytomegalovirus immune surveillance. Nature Rev. Immunol. 2, 831–844 (2002).
  Article CAS Google Scholar
• Mocarski, E. S. Immune escape and exploitation strategies of cytomegaloviruses: impact on and imitation of the major histocompatibility system. Cell. Microbiol. 6, 707–717 (2004).
  Article CAS PubMed Google Scholar
• Biron, C. A., Byron, K. S. & Sullivan, J. L. Severe herpesvirus infections in an adolescent without natural killer cells. N. Eng. J. Med. 320, 1731–1735 (1989). First report that humans without NK cells are particularly susceptible to herpesvirus infections.
  Article CAS Google Scholar
• Bukowski, J. F., Warner, J. F., Dennert, G. & Welsh, R. M. Adoptive transfer studies demonstrating the antiviral effect of natural killer cells in vivo. J. Exp. Med. 161, 40–52 (1985).
  Article CAS PubMed Google Scholar
• Cerwenka, A. & Lanier, L. L. Natural killer cells, viruses and cancer. Nature Rev. Immunol. 1, 41–49 (2001).
  Article CAS Google Scholar
• Scalzo, A. A., Fitzgerald, N. A., Simmons, A., La Vista, A. B. & Shellam, G. R. Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen. J. Exp. Med. 171, 1469–1483 (1990). Provides evidence that resistance to MCMV is conferred by a dominant gene in mice.
  Article CAS PubMed Google Scholar
• Lee, H. -S. et al. Susceptibility to mouse cytomegalovirus is associated with depletion of an activating natural killer cell receptor of the C-type lectin superfamily. Nature Genet. 28, 42–45 (2001).
  CAS PubMed Google Scholar
• Brown, M. G. et al. Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science 292, 934–937 (2001).
  Article CAS PubMed Google Scholar
• Daniels, K. A. et al. Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H. J. Exp. Med. 194, 29–44 (2001). References 20–22 implicate the Ly49H receptor in resistance to MCMV.
  Article CAS PubMed PubMed Central Google Scholar
• Smith, K. M., Wu, J., Bakker, A. B. H., Phillips, J. H. & Lanier, L. L. Cutting edge: Ly49D and Ly49H associate with mouse DAP12 and form activating receptors. J. Immunol. 161, 7–10 (1998).
  CAS PubMed Google Scholar
• Sjolin, H. et al. Pivotal role of KARAP/DAP12 adaptor molecule in the natural killer cell-mediated resistance to murine cytomegalovirus infection. J. Exp. Med. 195, 825–834 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Lee, S. H. et al. Transgenic expression of the activating natural killer receptor Ly49H confers resistance to cytomegalovirus in genetically susceptible mice. J. Exp. Med. 197, 515–526 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Arase, H., Mocarski, E. S., Campbell, A. E., Hill, A. B. & Lanier, L. L. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296, 1323–1326 (2002).
  Article CAS PubMed Google Scholar
• Smith, H. R. et al. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc. Natl Acad. Sci. USA 99, 8826–8831 (2002). References 26 and 27 identify the ligand of Ly49H as a viral glycoprotein with homology to MHC class I.
  Article CAS PubMed PubMed Central Google Scholar
• Voigt, V. et al. Murine cytomegalovirus m157 mutation and variation leads to immune evasion of natural killer cells. Proc. Natl Acad. Sci. USA 100, 13483–13488 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• French, A. R. et al. Escape of mutant double-stranded DNA virus from innate immune control. Immunity 20, 747–56 (2004).
  Article CAS PubMed Google Scholar
• Pereira, R. A., Scalzo, A. & Simmons, A. Cutting edge: a NK complex-linked locus governs acute versus latent herpes simplex virus infection of neurons. J. Immunol. 166, 5869–5873 (2001).
  Article CAS PubMed Google Scholar
• Beck, S. & Barrell, B. G. Human cytomegalovirus encodes a glycoprotein homologous to MHC class I antigens. Nature 331, 269–272 (1988).
  Article CAS PubMed Google Scholar
• Fahnestock, M. L. et al. The MHC class I homolog encoded by human cytomegalovirus binds endogenous peptides. Immunity 3, 583–590 (1995).
  Article CAS PubMed Google Scholar
• Farrell, H. E. et al. Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo. Nature 386, 510–514 (1997).
  Article CAS PubMed Google Scholar
• Reyburn, H. T. et al. The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells. Nature 386, 514–517 (1997).
  Article CAS PubMed Google Scholar
• Leong, C. C. et al. Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection: The role of endogenous class I MHC and a viral class I homolog. J. Exp. Med. 187, 1681–1687 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Cosman, D. et al. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 7, 273–282 (1997).
  Article CAS PubMed Google Scholar
• Chapman, T. L., Heikeman, A. P. & Bjorkman, P. J. The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18. Immunity 11, 603–613 (1999).
  Article CAS PubMed Google Scholar
• Cretney, E. et al. m144, a murine cytomegalovirus (MCMV)-encoded major histocompatibility complex class I homologue, confers tumor resistance to natural killer cell-mediated rejection. J. Exp. Med. 190, 435–444 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Tomasec, P. et al. Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science 287, 1031–1033 (2000).
  Article CAS PubMed Google Scholar
• Braud, V., Jones, E. Y. & McMichael, A. The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9. Eur. J. Immunol. 27, 1164–1169 (1997).
  Article CAS PubMed Google Scholar
• Braud, V. M. et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391, 795–798 (1998).
  Article CAS PubMed Google Scholar
• Ulbrecht, M. et al. Cutting edge: the human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis. J. Immunol. 164, 5019–5022 (2000).
  Article CAS PubMed Google Scholar
• Wang, E. C. et al. UL40-mediated NK evasion during productive infection with human cytomegalovirus. Proc. Natl Acad. Sci. USA 99, 7570–7575 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Cerboni, C. et al. Synergistic effect of IFN-γ and human cytomegalovirus protein UL40 in the HLA-E-dependent protection from NK cell-mediated cytotoxicity. Eur. J. Immunol. 31, 2926–2935 (2001).
  Article CAS PubMed Google Scholar
• Falk, C. S. et al. NK cell activity during human cytomegalovirus infection is dominated by US2–11-mediated HLA class I down-regulation. J. Immunol. 169, 3257–3266 (2002).
  Article CAS PubMed Google Scholar
• Wiertz, E. J. H. J. et al. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 84, 769–779 (1996).
  Article CAS PubMed Google Scholar
• Wiertz, E. J. H. J. et al. Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature 384, 432–438 (1996).
  Article CAS PubMed Google Scholar
• Barel, M. T. et al. Human cytomegalovirus-encoded US2 differentially affects surface expression of MHC class I locus products and targets membrane-bound, but not soluble HLA-G1 for degradation. J. Immunol. 171, 6757–6765 (2003).
  Article CAS PubMed Google Scholar
• Jones, T. R. et al. Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proc. Natl Acad. Sci. USA 93, 11327–11333 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Gruhler, A., Peterson, P. A. & Fruh, K. Human cytomegalovirus immediate early glycoprotein US3 retains MHC class I molecules by transient association. Traffic 1, 318–325 (2000).
  Article CAS PubMed Google Scholar
• Ahn, K. et al. The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity 6, 613–621 (1997).
  Article CAS PubMed Google Scholar
• Hengel, H. et al. A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter. Immunity 6, 623–632 (1997).
  Article CAS PubMed Google Scholar
• Wagner, M., Gutermann, A., Podlech, J., Reddehase, M. J. & Koszinowski, U. H. Major histocompatibility complex class I allele-specific cooperative and competitive interactions between immune evasion proteins of cytomegalovirus. J. Exp. Med. 196, 805–816 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Kleijnen, M. F. et al. A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface. EMBO J. 16, 685–694 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Kavanagh, D. G., Koszinowski, U. H. & Hill, A. B. The murine cytomegalovirus immune evasion protein m4/gp34 forms biochemically distinct complexes with class I MHC at the cell surface and in a pre-Golgi compartment. J. Immunol. 167, 3894–3902 (2001).
  Article CAS PubMed Google Scholar
• Holtappels, R. et al. The putative natural killer decoy early gene m04 (gp34) of murine cytomegalovirus encodes an antigenic peptide recognized by protective antiviral CD8 T cells. J. Virol. 74, 1871–1884 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Reusch, U. et al. A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation. EMBO J. 18, 1081–1091 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Oliveira, S. A., Park, S. H., Lee, P., Bendelac, A. & Shenk, T. E. Murine cytomegalovirus m02 gene family protects against natural killer cell-mediated immune surveillance. J. Virol. 76, 885–894 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Ziegler, H. et al. A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments. Immunity 6, 57–66 (1997).
  Article CAS PubMed Google Scholar
• Kavanagh, D. G., Gold, M. C., Wagner, M., Koszinowski, U. H. & Hill, A. B. The multiple immune-evasion genes of murine cytomegalovirus are not redundant. M4 and m152 inhibit antigen presentation in a complementary and cooperative fashion. J. Exp. Med. 194, 967–978 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Ishido, S. et al. Inhibition of natural killer cell-mediated cytotoxicity by Kaposi's sarcoma-associated herpesvirus K5 protein. Immunity 13, 365–74 (2000).
  Article CAS PubMed Google Scholar
• Coscoy, L. & Ganem, D. Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis. Proc. Natl Acad. Sci. USA 97, 8051–8056 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Coscoy, L. & Ganem, D. A viral protein that selectively downregulates ICAM-1 and B7-2 and modulates T cell costimulation. J. Clin. Invest. 107, 1599–1606 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Azuma, M., Cayabyab, M., Buck, D., Phillips, J. H. & Lanier, L. L. Involvement of CD28 in major histocompatibility complex-unrestricted cytotoxicity mediated by a human NK leukemia cell line. J. Immunol. 149, 1115–1123 (1992).
  CAS PubMed Google Scholar
• Nagler, A., Lanier, L. L., Cwirla, S. & Phillips, J. H. Comparative studies of human FcRIII-positive and negative NK cells. J. Immunol. 143, 3183–3191 (1989).
  CAS PubMed Google Scholar
• Fruh, K. et al. A viral inhibitor of peptide transporters for antigen presentation. Nature 375, 415–418 (1995).
  Article CAS PubMed Google Scholar
• Huard, B. & Fruh, K. A role for MHC class I down-regulation in NK cell lysis of herpes virus-infected cells. Eur. J. Immunol. 30, 509–515 (2000).
  Article CAS PubMed Google Scholar
• Shimizu, Y. & DeMars, R. Demonstration by class I gene transfer that reduced susceptibility of human cells to natural killer cell-mediated lysis is inversely correlated with HLA class I antigen expression. Eur. J. Immunol. 19, 447–451 (1989).
  Article CAS PubMed Google Scholar
• Storkus, W. J., Alexander, J., Payne, J. A., Dawson, J. R. & Cresswell, P. Reversal of natural killing susceptibility in target cells expressing transfected class I HLA genes. Proc. Natl Acad. Sci. USA 86, 2361–2364 (1989).
  Article CAS PubMed PubMed Central Google Scholar
• Bauer, S. et al. Activation of natural killer cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285, 727–730 (1999).
  Article CAS PubMed Google Scholar
• Jamieson, A. M. et al. The role of the NKG2D immunoreceptor in immune cell activation and natural killing. Immunity 17, 19–29 (2002).
  Article CAS PubMed Google Scholar
• Radosavljevic, M. & Bahram, S. In vivo immunogenetics: from MIC to RAET1 loci. Immunogenetics 55, 1–9 (2003).
  CAS PubMed Google Scholar
• Cosman, D. et al. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 14, 123–133 (2001). First evidence that an HCMV-encoded protein, UL16, binds to ligands for the activating NKG2D receptor.
  Article CAS PubMed Google Scholar
• Chalupny, J. N., Sutherland, C. L., Lawrence, W. A., Rein-Weston, A. & Cosman, D. ULBP4 is a novel ligand for human NKG2D. Biochem. Biophys. Res. Commun. 305, 129–135 (2003).
  Article PubMed CAS Google Scholar
• Groh, V. et al. Costimulation of CD8αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nature Immunol. 2, 255–260 (2001).
  Article CAS Google Scholar
• Welte, S. A. et al. Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein. Eur. J. Immunol. 33, 194–203 (2003).
  Article CAS PubMed Google Scholar
• Wu, J. et al. Intracellular retention of the MHC class I-related chain B ligand of NKG2D by the human cytomegalovirus UL16 glycoprotein. J. Immunol. 170, 4196–4200 (2003).
  Article CAS PubMed Google Scholar
• Dunn, C. et al. Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity. J. Exp. Med. 197, 1427–1439 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Rolle, A. et al. Effects of human cytomegalovirus infection on ligands for the activating NKG2D receptor of NK cells: up-regulation of UL16-binding protein (ULBP)1 and ULBP2 is counteracted by the viral UL16 protein. J. Immunol. 171, 902–908 (2003). References 76–79 indicate that HCMV UL16 retains selected human NKG2D ligand proteins intracellularly.
  Article PubMed Google Scholar
• Krmpotic, A. et al. MCMV glycoprotein gp40 confers virus resistance to CD8+ T cells and NK cells in vivo. Nature Immunol. 3, 529–535 (2002). References 80, 85, 87 and 90 show that MCMV encodes viral proteins that affect the expression of ligands for the mouse NKG2D receptor, and which therefore function as virulence factors.
  Article CAS Google Scholar
• Cerwenka, A. et al. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 12, 721–727 (2000).
  Article CAS PubMed Google Scholar
• Diefenbach, A., Jamieson, A. M., Liu, S. D., Shastri, N. & Raulet, D. H. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nature Immunol. 1, 119–126 (2000).
  Article CAS Google Scholar
• Carayannopoulos, L. N., Naidenko, O. V., Fremont, D. H. & Yokoyama, W. M. Cutting edge: murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for murine NKG2D. J. Immunol. 169, 4079–4083 (2002).
  Article CAS PubMed Google Scholar
• Diefenbach, A., Hsia, J. K., Hsiung, M. Y. & Raulet, D. H. A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity. Eur. J. Immunol. 33, 381–391 (2003).
  Article CAS PubMed Google Scholar
• Lodoen, M. et al. NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules. J. Exp. Med. 197, 1245–1253 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Ziegler, H., Muranyi, W., Burgert, H. G., Kremmer, E. & Koszinowski, U. H. The luminal part of the murine cytomegalovirus glycoprotein gp40 catalyzes the retention of MHC class I molecules. EMBO J. 19, 870–881 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Lodoen, M. et al. The cytomegalovirus m155 gene product subverts NK cell antiviral protection by disruption of H60-NKG2D interactions. J. Exp. Med. 200, 1075–1081 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Lorenzo, M. E., Jung, J. U. & Ploegh, H. L. Kaposi's sarcoma-associated herpesvirus K3 utilizes the ubiquitin-proteasome system in routing class major histocompatibility complexes to late endocytic compartments. J. Virol. 76, 5522–5531 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Zhan, X. et al. Mutagenesis of murine cytomegalovirus using a Tn_3_-based transposon. Virology 266, 264–274 (2000).
  Article CAS PubMed Google Scholar
• Abenes, G. et al. Murine cytomegalovirus with a transposon insertional mutation at open reading frame m155 is deficient in growth and virulence in mice. J. Virol. 78, 6891–6899 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Schwartz, O., Marechal, V., Le Gall, S., Lemonnier, F. & Heard, J. -M. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nature Med. 2, 338–342 (1996).
  Article CAS PubMed Google Scholar
• Le Gall, S. et al. Nef interacts with the μ subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC I molecules. Immunity 8, 483–495 (1998).
  Article CAS PubMed Google Scholar
• Le Gall, S. et al. Distinct trafficking pathways mediate Nef-induced and clathrin-dependent major histocompatibility complex class I down-regulation. J. Virol. 74, 9256–9266 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Cohen, G. B. et al. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 10, 661–671 (1999).
  Article CAS PubMed Google Scholar
• Martin, M. P. et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nature Genet. 31, 429–434 (2002). Epidemiological studies implicate KIR and HLA-B genes in protection against progression to AIDS.
  Article CAS PubMed Google Scholar
• Flores-Villanueva, P. O. et al. Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity. Proc. Natl Acad. Sci. USA 98, 5140–5145 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Xiang, Y. & Moss, B. IL-18 binding and inhibition of interferon-γ induction by human poxvirus-encoded proteins. Proc. Natl Acad. Sci. USA 96, 11537–11542 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Born, T. L. et al. A poxvirus protein that binds to and inactivates IL-18, and inhibits NK cell response. J. Immunol. 164, 3246–3254 (2000).
  Article CAS PubMed Google Scholar
• Wallace, G. D., Buller, R. M. & Morse, H. C. Genetic determinants of resistance to ectromelia (mousepox) virus-induced mortality. J. Virol. 55, 890–891 (1985).
  CAS PubMed PubMed Central Google Scholar
• Delano, M. L. & Brownstein, D. G. Innate resistance to lethal mousepox is genetically linked to the NK gene complex on chromosome 6 and correlates with early restriction of virus replication by cells with an NK phenotype. J. Virol. 69, 5875–5877 (1995).
  CAS PubMed PubMed Central Google Scholar
• Jacoby, R. O., Bhatt, P. N. & Brownstein, D. G. Evidence that NK cells and interferon are required for genetic resistance to lethal infection with ectromelia virus. Arch. Virol. 108, 49–58 (1989).
  Article CAS PubMed Google Scholar
• Chaudhri, G. et al. Polarized type 1 cytokine response and cell-mediated immunity determine genetic resistance to mousepox. Proc. Natl Acad. Sci. USA 101, 9057–9062 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Pileri, P. et al. Binding of hepatitis C virus to CD81. Science 282, 938–941 (1998).
  Article CAS PubMed Google Scholar
• Wack, A. et al. Binding of the hepatitis C virus envelope protein E2 to CD81 provides a co-stimulatory signal for human T cells. Eur. J. Immunol. 31, 166–175 (2001).
  Article CAS PubMed Google Scholar
• Tseng, C. T., Miskovsky, E. & Klimpel, G. R. Crosslinking CD81 results in activation of TCRγδ T cells. Cell. Immunol. 207, 19–27 (2001).
  Article CAS PubMed Google Scholar
• Tseng, C. T. & Klimpel, G. R. Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions. J. Exp. Med. 195, 43–49 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Crotta, S. et al. Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J. Exp. Med. 195, 35–41 (2002). References 106 and 107 indicate that HCV inhibits NK cell functions.
  Article CAS PubMed PubMed Central Google Scholar
• Khakoo, S. I. et al. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 305, 872–874 (2004). Epidemiological studies that implicate KIR and HLA genes in protective immune responses to HCV.
  Article CAS PubMed Google Scholar
• Karre, K., Ljunggren, H. G., Piontek, G. & Kiessling, R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319, 675–678 (1986).
  Article CAS PubMed Google Scholar
• Tortorella, D., Gewurz, B. E., Furman, M. H., Schust, D. J. & Ploegh, H. L. Viral subversion of the immune system. Annu. Rev. Immunol. 18, 861–926 (2000).
  Article CAS PubMed Google Scholar